HXBM logo

Helix BioMedix, Inc. Stock Price

OTCPK:HXBM Community·US$449.4k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

HXBM Share Price Performance

US$2.00
-6.00 (-75.00%)
US$2.00
-6.00 (-75.00%)
Price US$2.00

HXBM Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Helix BioMedix, Inc. Key Details

US$2.1m

Revenue

US$641.2k

Cost of Revenue

US$1.4m

Gross Profit

US$4.0m

Other Expenses

-US$2.6m

Earnings

Last Reported Earnings
Sep 30, 2012
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About HXBM

Founded
1988
Employees
n/a
CEO
Robin Carmichael
WebsiteView website
www.helixbiomedix.com

Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.

Recent HXBM News & Updates

No updates

Recent updates

No updates